Expression of protein elongation factor eEF1A2 predicts favorable outcome in breast cancer

By Kulkarni Geeta   Turbin Dmitry   Amiri Anahita   Jeganathan Sujeeve   Andrade-Navarro Miguel   Wu Thomas   Huntsman David   Lee Jonathan  

Breast Cancer Research and Treatment, Vol. 102, Iss. 1, 2007-03 ,pp. : 31-41

Springer Publishing Company

Access to resources Recommend Favorite

Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer

By Reijm E.  

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 387-394

Springer Publishing Company

Access to resources Recommend Favorite

High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer

By Jansen M.  

Breast Cancer Research and Treatment, Vol. 133, Iss. 3, 2012-06 ,pp. : 937-947

Springer Publishing Company

Access to resources Recommend Favorite

Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis

By Kobayashi Takayuki  

Breast Cancer Research and Treatment, Vol. 123, Iss. 3, 2010-10 ,pp. : 733-745

Springer Publishing Company

Access to resources Recommend Favorite

Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome

By Lobbezoo Dorien   Kampen Roel   Voogd Adri   Dercksen M.   den Berkmortel Franchette   Smilde Tineke   Wouw Agnes   Peters Frank   Riel Johanna   Peters Natascha   Boer Maaike   Borm George   Tjan-Heijnen Vivianne  

Breast Cancer Research and Treatment, Vol. 141, Iss. 3, 2013-10 ,pp. : 507-514

Springer Publishing Company

Access to resources Recommend Favorite